NASDAQ · Medical - Healthcare Information Services

SLP (SLP) Stock

$18.30 -0.16% NASDAQ: SLP Healthcare

Valuation

MetricValue
Price$18.30
Market Cap$370.11M
P/E Ratio-4.14
P/B Ratio2.16
P/S Ratio3.46
EPS (TTM)$-3.22
52-Week High$21.01
52-Week Low$11.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-52.00%
ROA-49.24%
ROCE-56.80%
Gross Margin-89.87%
Operating Margin-89.87%
Net Margin-77.96%
Debt/Equity0.01
Current Ratio7.43

Annual Financials (USD)

Metric20212022202320242025
Revenue$46.0M$54.0M$60.0M$70.0M$79.0M
Operating Profit$11.0M$15.0M$9.0M$6.0M$-71.0M
Net Profit$10.0M$12.0M$10.0M$10.0M$-65.0M
EPS$0.47$0.60$0.49$0.49$-3.22
Op Margin24.2%27.7%14.6%8.8%-89.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$182.0M$191.0M$193.0M$208.0M$132.0M
Total Liabilities$16.0M$12.0M$23.0M$25.0M$7.0M
Cash$37.0M$52.0M$58.0M$10.0M$31.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$1.0M

Latest News

Simulations Plus Fiscal Q3 Adjusted Earnings Decline, Revenue Rises MT Newswires · Jul 9, 2026 Simulations Plus: Fiscal Q3 Earnings Snapshot Associated Press · Jul 9, 2026 Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results Business Wire · Jul 9, 2026 [Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) GlobeNewswire · Jun 26, 2026 Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit Business Wire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$19.0M$18.0M$22.0M$13.0M$18.0M
Investing Cash Flow$-31.0M$0$3.0M$-55.0M$3.0M
Financing Cash Flow$-1.0M$-4.0M$-18.0M$-2.0M$-2.0M
Net Cash Flow$-12.0M$15.0M$6.0M$-47.0M$21.0M
Free Cash Flow$15.0M$14.0M$18.0M$13.0M$17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield8.54%
Quick Ratio5.47
Interest Coverage—
Return 1Y38.13%
Return 3Y-61.63%
Return 5Y-57.91%

Ownership

Insiders Held17.19%
Institutions Held82.66%
Institutions Float Held99.82%
Institutional HolderSharesReport Date
First Light Asset Management, LLC2,632,8232026-03-31
Blackrock Inc.1,252,3762026-03-31
Morgan Stanley887,5112026-03-31
First Eagle Investment Management, LLC742,0692026-03-31
Vanguard Capital Management LLC739,7212026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACIU $2.31 +0.22% -4.04 $234.59M 0.00%
AGL $99.07 +0.11% -3.60 $1.65B 0.00%
ANRO $28.67 +0.70% -6.29 $1.01B 0.00%
CLLSCellectis S.A. $2.81 -2.26% -4.14 $282.17M 0.00%
DH $0.67 -1.38% 4.29 $71.08M 0.00%

About SLP

SLP is led by CEO Shawn O'Connor, employs 243 people, headquartered in US, publicly traded since 1997.

SLP stock trades at $18.30 with a market capitalization of $370.11M. The stock is valued at a price-to-earnings (P/E) ratio of -4.14, price-to-book of 2.16, price-to-sales of 3.46. Over the past 52 weeks the stock has ranged between $11.09 and $21.01, and currently trades 12.9% below its 52-week high.

On profitability, SLP generates a return on equity (ROE) of -52.00%, return on capital employed of -56.80%, an operating margin of -89.87%, a net profit margin of -77.96%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides